Hanmi Pharm Co Ltd
KRX:128940

Watchlist Manager
Hanmi Pharm Co Ltd Logo
Hanmi Pharm Co Ltd
KRX:128940
Watchlist
Price: 278 000 KRW -1.07% Market Closed
Market Cap: 3.5T KRW
Have any thoughts about
Hanmi Pharm Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Hanmi Pharm Co Ltd stock under the Base Case scenario is 379 659.54 KRW. Compared to the current market price of 278 000 KRW, Hanmi Pharm Co Ltd is Undervalued by 27%.

Intrinsic Value
379 659.54 KRW
Undervaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Hanmi Pharm Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Hanmi Pharm Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Hanmi Pharm Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Hanmi Pharm Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Hanmi Pharm Co Ltd

Provide an overview of the primary business activities
of Hanmi Pharm Co Ltd.

What unique competitive advantages
does Hanmi Pharm Co Ltd hold over its rivals?

What risks and challenges
does Hanmi Pharm Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hanmi Pharm Co Ltd.

Provide P/S
for Hanmi Pharm Co Ltd.

Provide P/E
for Hanmi Pharm Co Ltd.

Provide P/OCF
for Hanmi Pharm Co Ltd.

Provide P/FCFE
for Hanmi Pharm Co Ltd.

Provide P/B
for Hanmi Pharm Co Ltd.

Provide EV/S
for Hanmi Pharm Co Ltd.

Provide EV/GP
for Hanmi Pharm Co Ltd.

Provide EV/EBITDA
for Hanmi Pharm Co Ltd.

Provide EV/EBIT
for Hanmi Pharm Co Ltd.

Provide EV/OCF
for Hanmi Pharm Co Ltd.

Provide EV/FCFF
for Hanmi Pharm Co Ltd.

Provide EV/IC
for Hanmi Pharm Co Ltd.

Show me price targets
for Hanmi Pharm Co Ltd made by professional analysts.

What are the Revenue projections
for Hanmi Pharm Co Ltd?

How accurate were the past Revenue estimates
for Hanmi Pharm Co Ltd?

What are the Net Income projections
for Hanmi Pharm Co Ltd?

How accurate were the past Net Income estimates
for Hanmi Pharm Co Ltd?

What are the EPS projections
for Hanmi Pharm Co Ltd?

How accurate were the past EPS estimates
for Hanmi Pharm Co Ltd?

What are the EBIT projections
for Hanmi Pharm Co Ltd?

How accurate were the past EBIT estimates
for Hanmi Pharm Co Ltd?

Compare the revenue forecasts
for Hanmi Pharm Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hanmi Pharm Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hanmi Pharm Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hanmi Pharm Co Ltd compared to its peers.

Compare the P/E ratios
of Hanmi Pharm Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Hanmi Pharm Co Ltd with its peers.

Analyze the financial leverage
of Hanmi Pharm Co Ltd compared to its main competitors.

Show all profitability ratios
for Hanmi Pharm Co Ltd.

Provide ROE
for Hanmi Pharm Co Ltd.

Provide ROA
for Hanmi Pharm Co Ltd.

Provide ROIC
for Hanmi Pharm Co Ltd.

Provide ROCE
for Hanmi Pharm Co Ltd.

Provide Gross Margin
for Hanmi Pharm Co Ltd.

Provide Operating Margin
for Hanmi Pharm Co Ltd.

Provide Net Margin
for Hanmi Pharm Co Ltd.

Provide FCF Margin
for Hanmi Pharm Co Ltd.

Show all solvency ratios
for Hanmi Pharm Co Ltd.

Provide D/E Ratio
for Hanmi Pharm Co Ltd.

Provide D/A Ratio
for Hanmi Pharm Co Ltd.

Provide Interest Coverage Ratio
for Hanmi Pharm Co Ltd.

Provide Altman Z-Score Ratio
for Hanmi Pharm Co Ltd.

Provide Quick Ratio
for Hanmi Pharm Co Ltd.

Provide Current Ratio
for Hanmi Pharm Co Ltd.

Provide Cash Ratio
for Hanmi Pharm Co Ltd.

What is the historical Revenue growth
over the last 5 years for Hanmi Pharm Co Ltd?

What is the historical Net Income growth
over the last 5 years for Hanmi Pharm Co Ltd?

What is the current Free Cash Flow
of Hanmi Pharm Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hanmi Pharm Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hanmi Pharm Co Ltd

Current Assets 739.3B
Cash & Short-Term Investments 246.9B
Receivables 188.7B
Other Current Assets 303.7B
Non-Current Assets 1.2T
Long-Term Investments 129.6B
PP&E 841.9B
Intangibles 85.3B
Other Non-Current Assets 179.6B
Current Liabilities 678.1B
Accounts Payable 46.5B
Accrued Liabilities 55.8B
Short-Term Debt 365.1B
Other Current Liabilities 210.7B
Non-Current Liabilities 241.2B
Long-Term Debt 73.7B
Other Non-Current Liabilities 167.4B
Efficiency

Earnings Waterfall
Hanmi Pharm Co Ltd

Revenue
1.6T KRW
Cost of Revenue
-693.6B KRW
Gross Profit
875.2B KRW
Operating Expenses
-612.8B KRW
Operating Income
262.4B KRW
Other Expenses
-78B KRW
Net Income
184.4B KRW

Free Cash Flow Analysis
Hanmi Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hanmi Pharm Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
ROE is Increasing
60/100
Profitability
Score

Hanmi Pharm Co Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hanmi Pharm Co Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
62/100
Solvency
Score

Hanmi Pharm Co Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hanmi Pharm Co Ltd

Wall Street analysts forecast Hanmi Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hanmi Pharm Co Ltd is 423 770.77 KRW with a low forecast of 292 900 KRW and a high forecast of 532 350 KRW.

Lowest
Price Target
292 900 KRW
5% Upside
Average
Price Target
423 770.77 KRW
52% Upside
Highest
Price Target
532 350 KRW
91% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Hanmi Pharm Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hanmi Pharm Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Hanmi Pharm Co Ltd Logo
Hanmi Pharm Co Ltd

Country

Korea

Industry

Pharmaceuticals

Market Cap

3.5T KRW

Dividend Yield

0.27%

Description

Hanmi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2010-07-30. The firm operates its business through three segments. The Pharmaceuticals segment manufactures and sells tablets, capsules, injections, syrups, powders and raw materials used in the treatment of hypertension, reflux esophagitis, influenza type A and influenza type B virus infections and hyperlipidemia, among others. The Other segment is engaged in the materials processing. The Export segment produces and sells products such as powders and injections, and exports technologies.

Contact

GYEONGGI-DO
Hwaseong
214, Muha-ro, Paltan-myeon
+82313505600
www.hanmi.co.kr

IPO

2010-07-30

Employees

-

Officers

Chief Executive Officer
Mr. Jae-Hyun Park
President of Business Development & Executive Director
Mr. Lim Chong-Yoon
Executive Director
Mr. Jong-Soo Woo Ph.D.
CSR Executive Director
Mr. Jong-Hoon Lim
Executive Director & Management Planning /CIO
Mr. Jong-Hoon Lim

See Also

Discover More
What is the Intrinsic Value of one Hanmi Pharm Co Ltd stock?

The intrinsic value of one Hanmi Pharm Co Ltd stock under the Base Case scenario is 379 659.54 KRW.

Is Hanmi Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 278 000 KRW, Hanmi Pharm Co Ltd is Undervalued by 27%.

Back to Top